Therapeutics

300+ Companies
More info
Parent markets
Sibling markets
Related markets
300+ companies in Therapeutics
Show all
Amgen Inc.

Amgen Inc.

Manufacturing +2
Seattle Genetics

Seattle Genetics

Health Care +2
Takeda

Takeda

Pharmaceuticals +1
Moderna Therapeutics

Moderna Therapeutics

Biotechnology +1
Aimmune

Aimmune

Health and Wellness +2
Nohla Therapeutics

Nohla Therapeutics

Biotechnology +2
Puma Biotechnology

Puma Biotechnology

Biotechnology +1
Scholar Rock

Scholar Rock

Medical +2
Pine Biotech

Pine Biotech

Big Data +3
NeuEve

NeuEve

E-Commerce +3
Joint Academy

Joint Academy

Cloud Computing +6
Harpoon Therapeutics

Harpoon Therapeutics

Health Care +1
Relay Therapeutics

Relay Therapeutics

Biotechnology +1
Cyteir

Cyteir

Biotechnology +1
Appili Therapeutics

Appili Therapeutics

Biotechnology +1
All companies in Therapeutics
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

18 Apr 2019
Talaris Therapeutics Inc
Talaris Therapeutics Inc
$100,000,000
Venture capital (Series A)
QiMing Venture Partners, Longitude Capital, Blackstone Life Sciences

Talaris lands $100 mln Series A

PE Hub
03 Apr 2019
Dyne Therapeutics
Dyne Therapeutics
$50,000,000
Venture capital (Series A)
MPM Capital, Forbion Capital Partners
03 Apr 2019
AgomAb Therapeutics
AgomAb Therapeutics
€21,000,000
Venture capital (Series A)
V-Bio Ventures, Advent France Biotechnology
01 Apr 2019
Candel Therapeutics
Candel Therapeutics
$22,500,000
Venture capital (Series C)
Northpond Ventures

Candel Therapeutics Completes $22.5M Series C Funding

FinSMEs
18 Mar 2019
Imara, Inc.
Imara, Inc.
$63,000,000
Venture capital (Series B)
OrbiMed
06 Mar 2019
Beam Therapeutics
Beam Therapeutics
$135,000,000
Venture capital (Series B)
Redmile Group, ARCH Venture Partners, Altitude Life Science Ventures, +5

Beam Therapeutics Secures $135M in Series B Financing

FinSMEs
28 Feb 2019
Maze Therapeutics
Maze Therapeutics
$191,000,000
Venture capital (Series A)
Foresite Capital, ARCH Venture Partners, Third Rock Ventures, +3
26 Feb 2019
Hookipa Pharma
Hookipa Pharma
$37,400,000
Venture capital (Series D)

Hookipa Pharma Raises $37.4M in Series D Financing

FinSMEs
13 Feb 2019
3-V Biosciences
3-V Biosciences
Venture capital (Series E)
Ascletis

Chinese Biotech Firm Ascletis Leads Series E Round In American Pharma 3-V Biosciences

ChinaMoneyNetwork
29 Jan 2019
Sphere Fluidics Ltd
Sphere Fluidics Ltd
$2,000,000
Venture capital

Sphere Fluidics Closes $2M Funding Round

FinSMEs
21 Jan 2019
Kaia Health
Kaia Health
$10,000,000
Venture capital (Series A)
Balderton Capital
15 Jan 2019
Vast Therapeutics
Vast Therapeutics
$15,000,000
Venture capital (Series A)
Cystic Fibrosis Foundation, Shionogi